植入式循环记录仪监测血液透析患者既往未识别心房颤动的发生率
本研究纳入66例血液透析的肾衰竭患者并植入循环记录仪,监测6个月。59例既往未诊断心房颤动者中18例(31%)检出持续≥6分钟的心房颤动,7例既往已诊断者中5例(71%)检出。透析液钙更高与心房颤动风险降低相关,透析液碳酸氢盐更高与风险升高相关。
要点
- 血液透析的肾衰竭患者中,既往未诊断心房颤动者经循环记录仪监测6个月,31%(18/59)检出持续≥6分钟的心房颤动。
- 23例检出心房颤动的患者中,心房颤动出现在16%的患者日,多数患者心房颤动负荷较低。
- 透析液钙>2.5 vs 2.5 mEq/l的房颤发生率比为0.62(95%CI 0.48-0.80);透析液碳酸氢盐>35 vs 35 mEq/l为3.18(95%CI 1.13-8.94)。
核心结论
- 血液透析的肾衰竭患者中约三分之一检出既往未诊断的心房颤动,心房颤动累及相当比例的患者日,可能是该人群卒中未被充分认识的原因。
研究设计与样本
- 纳入66例血液透析的肾衰竭患者并植入循环记录仪,在6个月监测期内捕获持续≥6分钟的心房颤动事件。
- 收集人口学、临床和透析特征,采用负二项回归模型估计与心房颤动发生的关联,以发生率比和95%CI表示。
主要发现
- 66例患者平均年龄56岁,70%为男性;59例(90%)既往未诊断心房颤动。
- 59例既往未诊断心房颤动者中18例(31%)检出持续≥6分钟的心房颤动,7例既往已诊断者中5例(71%)检出。
- 23例检出心房颤动的患者中,心房颤动出现在16%的患者日;14例(61%)心房颤动日占监测日<5%,13例(52%)心房颤动平均持续时间<1小时。
- 23例心房颤动≥6分钟的患者中,19例(83%)CHA2DS2-VASc评分≥2。
- 透析液钙>2.5 vs 2.5 mEq/l与心房颤动风险降低相关(发生率比=0.62;95%CI 0.48-0.80),透析液碳酸氢盐>35 vs 35 mEq/l与心房颤动风险升高相关(发生率比=3.18;95%CI 1.13-8.94)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Atrial fibrillation (AF) is common in patients with kidney failure on hemodialysis (KF-HD). We determined both AF incidence and burden in patients with KF-HD using implantable loop recorder (ILR) monitoring. METHODS: Patients with KF-HD were enrolled and received an ILR. In 6 monitoring months, the incidence of AF events lasting ≥6 minutes was captured. Demographic, clinical, and dialysis characteristics were collected, and associations with incident AF were estimated using negative binomial regression models and expressed as incidence rate ratios and 95% CIs. RESULTS: We enrolled 66 patients with KF-HD (mean age = 56 years, 70% male); 59 (90%) were without previously diagnosed AF. AF lasting ≥6 minutes was detected in 18 of 59 subjects (31%) without previously diagnosed AF and in 5 of 7 subjects (71%) with a previous AF diagnosis. Among the 23 with detected AF, episodes were present on 16% of patient days. Although 14 of 23 patients (61%) had AF on <5% of monitored days, the average duration of AF episodes was <1 hour in 13 of 23 patients (52%). Among patients with AF ≥6 minutes, 19 of 23 (83%) had a CHA2DS2-VASc score ≥2. When investigating individual HD parameters, higher dialysate calcium (>2.5 vs. 2.5 mEq/l: incidence rate ratio = 0.62; 95% CI, 0.48-0.80) was associated with lower AF risk whereas higher dialysate bicarbonate concentrations (>35 vs. 35 mEq/l: incidence rate ratio = 3.18; 95% CI, 1.13-8.94) were associated with higher AF risk. CONCLUSION: New AF was detected in approximately one-third of patients with KF-HD. AF affects a substantial proportion of patient days and may be an underappreciated cause of stroke in KF-HD.
引用
- Koplan BA, Winkelmayer WC, Costea AI, et al. Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis. Kidney Int Rep. 2021. PMID: 35155858. doi:10.1016/j.ekir.2021.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。